FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3199891704> ?p ?o ?g. }

• W3199891704 abstract "This study aimed to evaluate the bone turnover markers and bone microarchitecture parameters derived from high-resolution peripheral quantitative computed tomography (HR-pQCT) in active and controlled acromegaly patients.This cross-sectional study involved 55 acromegaly patients from a tertiary hospital (23 males and 32 females, aged 45.0 ± 11.6 years). Firstly, growth hormone (GH), insulin-like growth factor-1 (IGF-1), and markers for bone turnover were assessed. Next, we derived peripheral bone microstructure parameters and volumetric bone mineral density (vBMD) through HR-pQCT. These parameters were compared between acromegaly patients and 110 healthy controls, as well as between 27 active and 28 controlled acromegaly patients. Moreover, the relationship between GH/IGF-1 and bone microstructure parameters was analyzed through multiple linear regression.As compared with healthy controls, acromegaly patients exhibited elevated cortical vBMD, reduced trabecular vBMD, and increased trabecular inhomogeneity in the distal radius and tibia. While controlled acromegaly patients had slower bone turnover, they did not necessarily have better bone microstructure relative to active patients in intergroup comparison. Nevertheless, multiple regression indicated that higher IGF-1 was associated with lower tibial stiffness and failure load. Additionally, males with higher IGF-1 typically had larger trabecular separation, lower trabecular number, and larger cortical pores in the radius. Moreover, patients with elevated GH typically had more porous cortical bone in the radius and fewer trabeculae in the tibia. However, the compromised bone strength in active patients was partially compensated by increased bone thickness. Furthermore, no significant linkage was observed between elevated GH/IGF-1 and the most important HR-pQCT parameters such as trabecular volumetric bone density.Acromegaly adversely affected bone quality, even in controlled patients. As the deterioration in bone microstructure due to prolonged GH/IGF-1 exposure was not fully reversible, clinicians should be aware of the bone fragility of acromegaly patients even after they had achieved biochemical remission." @default.
• W3199891704 created "2021-09-27" @default.
• W3199891704 creator A5002295462 @default.
• W3199891704 creator A5005351185 @default.
• W3199891704 creator A5012790647 @default.
• W3199891704 creator A5015025675 @default.
• W3199891704 creator A5039380491 @default.
• W3199891704 creator A5042656907 @default.
• W3199891704 creator A5049812267 @default.
• W3199891704 creator A5054551633 @default.
• W3199891704 creator A5068009587 @default.
• W3199891704 creator A5068176076 @default.
• W3199891704 creator A5069441309 @default.
• W3199891704 creator A5070801947 @default.
• W3199891704 creator A5085187324 @default.
• W3199891704 date "2021-09-15" @default.
• W3199891704 modified "2023-10-10" @default.
• W3199891704 title "The Negative Impacts of Acromegaly on Bone Microstructure Not Fully Reversible" @default.
• W3199891704 cites W1981238527 @default.
• W3199891704 cites W2004508160 @default.
• W3199891704 cites W2008252191 @default.
• W3199891704 cites W2044178924 @default.
• W3199891704 cites W2047221936 @default.
• W3199891704 cites W2051147526 @default.
• W3199891704 cites W2066056548 @default.
• W3199891704 cites W2069348814 @default.
• W3199891704 cites W2085052047 @default.
• W3199891704 cites W2096131890 @default.
• W3199891704 cites W2099326137 @default.
• W3199891704 cites W2105233774 @default.
• W3199891704 cites W2113523811 @default.
• W3199891704 cites W2118793476 @default.
• W3199891704 cites W2133582792 @default.
• W3199891704 cites W2146832928 @default.
• W3199891704 cites W2155465275 @default.
• W3199891704 cites W2162957019 @default.
• W3199891704 cites W2406459505 @default.
• W3199891704 cites W2517442233 @default.
• W3199891704 cites W2578511026 @default.
• W3199891704 cites W2765975760 @default.
• W3199891704 cites W2771440762 @default.
• W3199891704 cites W2795288274 @default.
• W3199891704 cites W2802757031 @default.
• W3199891704 cites W2891991898 @default.
• W3199891704 cites W3127707228 @default.
• W3199891704 cites W4232121695 @default.
• W3199891704 doi "https://doi.org/10.3389/fendo.2021.738895" @default.
• W3199891704 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8479105" @default.
• W3199891704 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34603213" @default.
• W3199891704 hasPublicationYear "2021" @default.
• W3199891704 type Work @default.
• W3199891704 sameAs 3199891704 @default.
• W3199891704 citedByCount "8" @default.
• W3199891704 countsByYear W31998917042022 @default.
• W3199891704 countsByYear W31998917042023 @default.
• W3199891704 crossrefType "journal-article" @default.
• W3199891704 hasAuthorship W3199891704A5002295462 @default.
• W3199891704 hasAuthorship W3199891704A5005351185 @default.
• W3199891704 hasAuthorship W3199891704A5012790647 @default.
• W3199891704 hasAuthorship W3199891704A5015025675 @default.
• W3199891704 hasAuthorship W3199891704A5039380491 @default.
• W3199891704 hasAuthorship W3199891704A5042656907 @default.
• W3199891704 hasAuthorship W3199891704A5049812267 @default.
• W3199891704 hasAuthorship W3199891704A5054551633 @default.
• W3199891704 hasAuthorship W3199891704A5068009587 @default.
• W3199891704 hasAuthorship W3199891704A5068176076 @default.
• W3199891704 hasAuthorship W3199891704A5069441309 @default.
• W3199891704 hasAuthorship W3199891704A5070801947 @default.
• W3199891704 hasAuthorship W3199891704A5085187324 @default.
• W3199891704 hasBestOaLocation W31998917041 @default.
• W3199891704 hasConcept C126322002 @default.
• W3199891704 hasConcept C134018914 @default.
• W3199891704 hasConcept C141071460 @default.
• W3199891704 hasConcept C142724271 @default.
• W3199891704 hasConcept C170033053 @default.
• W3199891704 hasConcept C2776541429 @default.
• W3199891704 hasConcept C2776886416 @default.
• W3199891704 hasConcept C2777236700 @default.
• W3199891704 hasConcept C2777425516 @default.
• W3199891704 hasConcept C2777433750 @default.
• W3199891704 hasConcept C2781451080 @default.
• W3199891704 hasConcept C2984496839 @default.
• W3199891704 hasConcept C71315377 @default.
• W3199891704 hasConcept C71924100 @default.
• W3199891704 hasConceptScore W3199891704C126322002 @default.
• W3199891704 hasConceptScore W3199891704C134018914 @default.
• W3199891704 hasConceptScore W3199891704C141071460 @default.
• W3199891704 hasConceptScore W3199891704C142724271 @default.
• W3199891704 hasConceptScore W3199891704C170033053 @default.
• W3199891704 hasConceptScore W3199891704C2776541429 @default.
• W3199891704 hasConceptScore W3199891704C2776886416 @default.
• W3199891704 hasConceptScore W3199891704C2777236700 @default.
• W3199891704 hasConceptScore W3199891704C2777425516 @default.
• W3199891704 hasConceptScore W3199891704C2777433750 @default.
• W3199891704 hasConceptScore W3199891704C2781451080 @default.
• W3199891704 hasConceptScore W3199891704C2984496839 @default.
• W3199891704 hasConceptScore W3199891704C71315377 @default.
• W3199891704 hasConceptScore W3199891704C71924100 @default.
• W3199891704 hasFunder F4320335777 @default.
• W3199891704 hasLocation W31998917041 @default.

• next